Dutch Government Will Not Mandate Masks, Says ‘No Proven Effectiveness’

  • Thread starter Thread starter Cathoholic
  • Start date Start date
Status
Not open for further replies.
LeafByNiggle . . .
Why is New Zealand missing from this chart?
I don’t know.

New Zealand was frequently using hydroxychloroquine before the FAKE Lancet and NEJM studies were published and the WHO said based on that, discouraged the use of hydroxychloroquine as a result and suspended its own WHO studies on hydroxychloroquine (the WHO to its credit, has resumed these hydroxychloroquine studies but to my knowledge has not retracted its recomendation for others to suspend their studies which is puzzling).

As you know from our prior discussions, the FAKE “studies” had to be retracted. But again the WHO recomendations for others studying hydroxychloroquine in corona virus infection of course were not changed (at least to my knowledge) despite re-starting their own studies.

.

Coronavirus: What is hydroxychloroquine and why is New Zealand throwing money at it?​

Bridie Witton13:40, May 29 2020

The once-obscure drug Hydroxychloroquine has rocketed into global prominence, labelled everything from snake oil to a Covid-19 miracle cure. . . .

. . . This week the drug was suspended from the WHO’s trail of potential Covid-19 treatments, after a new study published in the Lancet found it increases the risk of death and heart problems for infected patients. . . .
.

Regarding the FAKE “studies” attacking hydroxychloroquine usage . . .
. . . Three of the study’s authors said they could no longer vouch for its veracity because Surgisphere, a healthcare firm behind the data, would not allow an independent review of its dataset.

Its findings led the World Health Organisation to suspend its testing on the anti-malaria drug. . . .

. . . Mandeep Mehra, a Harvard University professor who led the study, together with Frank Ruschitzka of the University Hospital Zurich and Amit Patel of the University of Utah, said in a statement that they had tried to arrange for a third-party peer review of the data, but Surgisphere had refused to co-operate.

“We deeply apologise to you, the editors, and the journal readership for any embarrassment or inconvenience that this may have caused,” the group added. . .
 
India has not fallen for the FAKE studies (which have been characterized as a “sideshow”) or the premature and wrong WHO recomendations to stop hydroxychloroquine research.

Open letter​

Nearly 150 doctors signed an open letter to The Lancet last week calling the article’s conclusions into question and asking to make public the peer review comments that preceded publication.

Why is India pushing ahead with hydroxychloroquine?

“This is not some sideshow or minor issue,” said Walid Gellad, a Professor at University of Pittsburgh’s medical school, who was not a signatory of the letter but has been critical of the study. “We’re in an unprecedented pandemic. We’ve organised these enormous clinical trials to figure out if something works. And this study stopped or paused a couple of those trials, and changed the narrative around a drug that no one knows if it works or not,” he said.

The observational study was published in The Lancet on May 22. looked at 96,000 hospitalised COVID-19 patients, some treated with the decades-old malaria drug that Mr. Trump said he took and has urged others to use.

Several clinical trials were put on hold after the study was published.

The study, using data provided by healthcare data analytics firm Surgisphere, was not a traditional clinical trial that would have compared hydroxychloroquine to a placebo or other medicine.

The Lancet ’s editors said in a note that serious scientific questions about the study were brought to their attention and an independent audit of the data has already been commissioned. . .
 
Last edited:
LeafByNiggle . . .
Why is New Zealand missing from this chart?
Well, I do. New Zealand does not fit the narrative that chart wants to tell. It has a low case fatality rate, and yet does not generally give HCQ to their citizens.
New Zealand was frequently using hydroxychloroquine …
Were they? I don’t think so. The article you reported showed that there were testing it. They were not using it in the general population.
before the FAKE Lancet and NEJM studies were published…
The retraction of a study finding things against HCQ is not proof that it works, but if that’s the only drum you have you might as well beat it.
Regarding the FAKE “studies” attacking hydroxychloroquine usage . . .
And here we go again…

Instead of attacking studies that show HCQ doesn’t work, what is needed are studies that show it does work. But there are none. Only “suggestions.”
 
Well, I do. New Zealand does not fit the narrative that chart wants to tell. It has a low case fatality rate, and yet does not generally give HCQ to their citizens.
More proof that no one really knows what works best. Leaders are doing their best, except maybe China.
 
40.png
LeafByNiggle:
Well, I do. New Zealand does not fit the narrative that chart wants to tell. It has a low case fatality rate, and yet does not generally give HCQ to their citizens.
More proof that no one really knows what works best.
That goes doubly and triply for individuals deciding for themselves with no scientific backing what works best. Yet that is exactly what will happen when you disregard the best advice there is.
 
That goes doubly and triply for individuals deciding for themselves with no scientific backing what works best.
It also goes for those who have the medical and scientific background, but get silenced by no-nothing big tech because of politics.
Yet that is exactly what will happen when you disregard the best advice there is.
The best advice there is is regularly changing their minds. That said, I wear a mask. I social distance. I avoid large crowds including protesters.
 
LeafByNiggle insists hydroxychloroquine is in low demand in New Zealand because the doctors there do “not generally give HCQ to their citizens”.

Yet elsewhere LeafByNiggle was saying the doctors in countries with high usage do so because they are under pressure by their patients.

Patients in New Zealand do not seem to apply pressure or New Zealand doctors must have some gene or other factor, that makes them better suited to fight off patients alleged demands for hydroxychloroquine.

Again LeafByNiggle suggests hydroxychloroquine is in low demand in New Zealand because the doctors there do “not generally give HCQ to their citizens”.

Yet here is what a New Zealand source says hydroxychloroquine is (now “was”) in “high demand”. Why would it now be in “high demand” if a only a paucity of New Zealand physicians were not using it?? . . .

Covid-19 coronavirus: ‘Game changer’ drug in high demand in New Zealand​

3 Apr, 2020 9:11am

. . . Pharmac’s director of operations, Lisa Williams, said until now hydroxychloroquine had been an open listed drug on the Pharmac schedule, meaning that it could be prescribed “for anyone by anyone”. . . .

. . . "There’s been a lot of interest in the use of this product for treatment of Covid-19. But there hasn’t been any specific evidence to date to confirm that it works for that," Williams said.

"We’ve been seeing a lot more demand for that and hearing from community pharmacy and general practitioners that they were under pressure to prescribe and dispense this product."

Pharmac has now restricted access to the drug to patients who need it for rheumatoid arthritis, lupus and malaria.

LeafByNiggle . . .
Why is New Zealand missing from this chart?
Cathoholic . . .
I don’t know.
LeafByNiggle (so far with nothing but an ipse dixit fallacy [meanning “It is so because I say it’s so!”]). . .
Well, I do. New Zealand does not fit the narrative that chart wants to tell. It has a low case fatality rate, and yet does not generally give HCQ to their citizens.
Sure Leaf.
 
Last edited:
40.png
LeafByNiggle:
Yet that is exactly what will happen when you disregard the best advice there is.
The best advice there is is regularly changing their minds.
“Regularly” is an inaccurate description. They offer different advice when conditions change or new information comes to light. That is the way science has always worked.
 
Regularly” is an inaccurate description. They offer different advice when conditions change or new information comes to light. That is the way science has always worked.
And they do it regularly. That’s not a criticism.
I think it would be more concerning if they didn’t.
 
FWIW, I trust Oxford, University of Chicago, and Johns Hopkins. I distrust Trump and Pfizer.
 
Status
Not open for further replies.
Back
Top